Artificial Pancreas Device System Market Growth, Size, Share, Industry Report and Forecast 2019-2025
The global artificial pancreas device system market is estimated to grow at an impressive growth rate of 55% during the forecast period. Artificial pancreas technology can be stated as the next step in the field of integrating insulin delivery systems and glucose monitoring. It is projected to boost the global diabetes care device industry as a major breakthrough in treating and management of diabetes.
To Request a Sample of our Report on Artificial Pancreas Device System Market: https://www.omrglobal.com/request-sample/artificial-pancreas-device-system-market
The US Food and Drug
Administration (FDA) and Juvenile Diabetes Research Foundation (JRDF) are
working in collaboration with continuous glucose monitoring system
manufacturers in order to develop an artificial pancreas device system. This
would enhance the growth of the global artificial pancreas device system
market. Artificial pancreas is being developed with the aim to enhance the
insulin delivery system as well as to help in attaining normal glucose levels.
Continuous glucose monitoring systems attached to the insulin delivery systems
would automatically trigger insulin delivery.
The main aim of this project is to develop an effective artificial pancreas prototype for Type-1 diabetic patients. A continuous glucose monitoring system communicating with an insulin delivery pump is merged with the assistance of an artificial pancreas system. Such initiatives would expand the global artificial pancreas device system market size during the forecast period.
A
full Report of Artificial Pancreas Device System Market is Available
at: https://www.omrglobal.com/industry-reports/artificial-pancreas-device-system-market
·
On the basis of the type, the threshold
suspended device system segment is estimated to hold a dominating market share
during the forecast period.
·
North America is estimated to dominate the
global artificial pancreas device system industry during the forecast period.
·
Threshold Suspended Device System
·
Insulin-Only System
·
Bi-Hormonal Control System
North America
·
United
States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of
Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest of
APAC
Rest of The
World
·
Latin
America
·
Middle
East and Africa
Company
Profiles
·
Admetsys
Corp.
·
Beta
Bionics
·
Beta-O2
Technologies Ltd.
·
Bigfoot
Biomedical Inc.
·
Companion
Medical Inc.
·
Defymed
SAS
·
Dexcom
Inc.
·
Eli
Lilly and Co.
·
Inreda
Diabetic BV
·
Insulet
Corp.
·
Johnson
& Johnson Services Inc.
·
Medtronic
PLC
·
Pancreum,
Inc.
·
Tandem
Diabetes Care, Inc.
Reasons
to Buying From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/artificial-pancreas-device-system-market
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment